Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Moxifloxacin Dexamethasone Eyedrop 0.5% (10 ml)

₹ 148/Piece

Strength0.5%
Bottle Size10 ml
PreservativeBest Quality in Medicine in the market
Packaging TypeBottle
BrandArvantis
Shelf Life24 month
Packaging Size10 ml
Country of OriginMade in India
AvailabilityIn Stock
Moxifloxacin + Dexamethasone Eye Drops – A combination ophthalmic solution used to treat bacterial eye infections and reduce inflammation, redness, and swelling in conditions like conjunctivitis and post-surgical eye care.

Exports To: United States Of America | Sri Lanka | Saudi Arabia | Afghanistan | Ethiopia

Find products similar to Moxifloxacin Dexamethasone Eyedrop 0.5% (10 Ml)

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNew Delhi
ShippingAs per delivery location

Product Image

Moxifloxacin Dexamethasone Eyedrop 0.5% (10 ml)-1Moxifloxacin Dexamethasone Eyedrop 0.5% (10 ml)-2Moxifloxacin Dexamethasone Eyedrop 0.5% (10 ml)-3Moxifloxacin Dexamethasone Eyedrop 0.5% (10 ml)-4

About the Company

GST Registration Date
Dec 2022
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Mar 2023
GST
07**********2ZY
Import Export Code (IEC)
*******96P
Exports to
United States Of America | Sri Lanka | Saudi Arabia | Afghanistan | Ethiopia

Established in the year 2022, we “Arvantis Pharmaceuticals” are Wholesaler/Distributor of a Medicine. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Gopal Dass Nagpal, whose continual backing and direction have been useful to us for attaining exponential development in the current market.